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Abstract
Advanced glycation endproducts (AGEs) have been 
reported to play a role in neointimal formation and in-
crease the rate of in-stent restenosis (ISR) in the dia-
betic coronary artery disease patients treated with 
stents, but the potential pathogenic mechanisms of 
AGEs in vascular smooth muscle cell proliferation re-
main unclear. We sought to determine the AGEs related 
pathobiological mechanism of diabetic vasculopathy. 
Rat aortic smooth muscle cell (RAoSMC) culture was 
done with different concentrations of AGEs and pro-
liferation was assessed. Immunohistochemistry for re-
ceptor of AGEs (RAGE) was performed with human ca-
rotid atheroma. Western blotting was performed to as-
sess the activation of MAP kinase system in the cul-
tured RAoSMC. AGEs increased RAoSMC prolifera-
tion and were associated with increased phosphor-
ylation of ERK and p38 kinase by time and dose de-
pendent manner. The MAP kinase activity was de-
creased by RNA interference for RAGE. AGEs stim-
ulation increased reactive oxygen species (ROS) gen-
eration in cultured RAoSMC. From this study it is con-
cluded that AGEs played a key role in RAoSMC pro-
liferation via MAP kinase dependent pathways. 
Activation of vascular smooth muscle cell (VSMC) pro-
liferation by MAP kinase system and increased for-
mation of ROS may be the possible mechanisms of 
AGEs induced diabetic vasculopathy. 
Keywords: atherosclerosis; blood vessels; diabetes 
mellitus; glycation end products, advanced; mi-
togen-activated protein kinases
Introduction
The factors underlying accelerated atherosclerosis 
in diabetes extend beyond dyslipidemia, hyperten-
sion and obesity. Even after correction of these 
typical risk factors and rigorous control of hyper-
glycemia, diabetic patients continue to experience 
increased atherosclerotic vascular disease so called 
diabetic vasculopathy (Kannel and McGee, 1979; 
Uusitupa et al., 1990; DCCT research group, 1993). 
In the era of drug eluting stents (DES), the rate of 
ISR and major adverse cardiac event (MACE) after 
stenting are still higher in diabetic patients, affecting 
25% of patients treated with coronary artery stenting 
(Van Belle et al., 1997). It is assumed to be the 
result of neointimal formation characterized by 
migration and proliferation of VSMCs, however, the 
pathogenic mechanisms leading to the exaggerated 
restenosis in diabetes are poorly understood 
(Kornowski et al., 1998). AGEs have been linked to 
the development of various complications in long 
standing diabetes (Brownlee et al., 1988). Several 
studies have demonstrated that AGEs and its 
receptor/ligand interaction play a role in neointima 
formation after vascular injury irrespective of dia-
betes status and these findings suggest a novel 
target to minimize neointimal hyperplasia (Sakaguchi 
et al., 2003; Stephenson et al., 2003; Zhou et al., 
2003). Activation of RAGE results in both removal 
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of irreversibly glycosylated molecules, and acti-
vation of cell function, including secretion of various 
cytokines, which may subsequently induce the 
proinflammatory mediators (Vlassara et al., 1994; 
Bierhaus et al., 1997). However, the role of AGEs 
in the signaling pathways of VSMC proliferation 
remains to be elucidated. 
We hypothesized that increased VSMC prolife-
ration in diabetic vasculopathy is associated with 
AGEs and activation of the MAPK system may be 
one of the pathobiologic mechanism. Furthermore, 
we also investigated the association between AGEs 
and formation of intracellular ROS. 
Materials and Methods
This investigation was conducted after our institu-
tional review board authorization and also conforms 
with the principles outlined in the Declaration of 
Helsinki (Cardiovascular Research 1997;35:2-4) 
and with the Guide for the Care and Use of Labo-
ratory Animals (NIH Publication 85-23).
Reagents
Collagenase type IA and elastase for cell preparation 
were obtained from Sigma Chemical Co. (St.Louis, 
MO). Phospho-ERK, phospho-JNK, and phospho-p38 
antibodies were from New England Biolabs (Beverly, 
MA). DMEM and Dulbecco's FBS were obtained 
from Gibco Life technologies (Gaithersburg, MD). 
PVDF transfer membrane and ECL Western blotting 
detection system were purchased from NEN Life 
Science Products (Boston, MA) and Amersham (Little 
Chalfont, England), respectively. Reverse Transcrip-
tion System was obtained from Promega Co. 
(Madison, WI). 
Tissue preparation and immunochemical analysis in 
human atheroma specimens
Human carotid endarterectomy specimens (n = 9) 
were obtained from diabetic patients undergone 
carotid endarterectomy. Each specimen was fixed 
with 10% buffered formalin and embedded in paraffin. 
Immunohistochemistry was performed using poly-
clonal monospecific antibodies to RAGE (Santa 
Cruz Biotechnology, Santa Cruz, CA). Peroxidase- 
conjugated goat anti-rabbit IgG (Sigma Chemical 
Co.) was used to visualize the sites of primary 
antibody binding to the antigen.
Isolation and culture of RAoSMC and preparation of 
AGEs
RAoSMCs were isolated as previously described 
(Lee et al., 2004). Breifly, the aorta was enzyma-
tically isolated from the thoracic aortas from 6-8 
weeks-old Spraque-Dawley rats. The aorta was 
transferred into a plastic tube containing 5 ml of the 
enzyme dissociation mixture and was incubated for 
2 h at 37oC. The suspension was centrifuged 
(1,500 rpm for 10 min) and the pellet was resus-
pended in DMEM with 10% FBS. Cells were 
cultured over several passages (up to 15). RAoSMC 
were cultured in DMEM supplemented with 10% 
FCS, 100 IU/ml penicillin, 100 μg/ml streptomysin 
in 75-cm2 flasks at 37oC in a humidified atmo-
sphere of 90% air and 10% CO2 (Forma Scientific, 
Marietta, OH). 
RAoSMCs culture was done with different con-
centrations of AGEs stimulation (1.0, 10, 100, 1,000 
μg/ml). AGE-BSA was prepared by incubating BSA 
(WAKO, Tokyo, Japan) in PBS with 0.7 M glucose 
for 6 mo at 37oC.
Measurement of cell proliferation
Cell proliferation was measured by PreMix WST-1 
Cell Proliferation Assay System (Takara Biome-
dicals, Tokyo, Japan). This system enables the 
measurement of cell proliferation with colorimetric 
assay, and bases on the cleavage of slightly red 
tetrazolium salt (WST-1) by mitochondrial succinate- 
tetrazolium reductase in viable cells. As the 
increase in enzymes activity leads to an increase 
of the production of formazan dye, the quantity of 
formazan dye is related directly to the number of 
metabolically active cells in the medium. Cells (5-7
× 103) were seeded into wells of a 96-well culture 
plate and incubated with AGE for the times 
indicated. WST-1 cell proliferation reagent was added 
directly to the supernatant (10 μl/ 100μl growth 
medium), and incubated at 37oC for 3h. The absor-
bancy of the solubilized dark red formazan product 
was then determined at 450 nm.
Immunoblot analysis
Confluent RAoSMCs were cultured for 48 h in 
serum-free DMEM and were pre-treated with AGE 
(0∼100 μg/ml) for 1 d at 37oC. After treatment with 
different concentration of AGE, cells were rinsed in 
ice-cold PBS and treated with lysis buffer (1% 
Triton X-100, 0.1% mercaptoethanol, 1 mM EDTA, 
1 mM EGTA, 50 mM Tris-HCl (pH 7.0), 1 mM 
PMSF) for 20 min on ice. Cell lysates were 
collected into microcentrifuge tubes, vortexed, and 
centrifuged at 12,000 rpm for 20 min. Protein 
concentration was measured in the supernatant 
using a DC protein assay reagent according to the 
manufacturer's instructions and equalized for all 
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Figure 1. Immunohistochemistry of RAGE in human carotid atheroma. RAGE was stained as dark brown within atheromatous plaques. RAGE stained 
cells were distributed mainly in the base of atherosclerotic plaque, in the medio-intimal junction area and its immunoreactivity was co-localized with macro-
phage, mononuclear cells and smooth muscle cells. Arrow indicates RAGE stained smooth muscle cells.
samples. Reduced samples (30 g) were subjected 
to SDS–PAGE (NuPAGE 4-12% Bis-Tris gel) and 
then electrotransferred to nitrocellulose membrane. 
For detection of phosphorylated ERK-1/2, mem-
branes were incubated with antibody directed 
against a phospho-specific ERK-1/2 followed by 
incubation with goat anti-rabbit IgG conjugated to 
HRP. ECL detection method was employed for color 
development
RNA interference
For function-blocking experiments, we used small 
interfering RNA molecules (siRNA) targeted at 
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Figure 3. Effects of AGEs on phosphorylation of MAPKs in RAoSMC. 
Western blot analysis of p-ERK, p-JNK, p-P38 were performed in cul-
tured RAoSMC with or without AGE stimulation. Compared with control 
group, VSMC cultured with 50 μg/ml concentration AGE stimulation re-
vealed increased phosphorylation of MAPK system. Activity of p-ERK 
and p-P38 was markedly increased in AGE stimulated group comparing 
with p-JNK.
Figure 2. Effect of age stimulation in cultured RAoSMC by colorimetric 
assay. When compared with control, AGEs stimulation group showed in-
creased smooth muscle proliferation until AGEs concentration 100 μg/ml 
by concentration dependent manner.
RAGE mRNA. A 21-nt sequence for siRNA was 
derived from the rat RAGE (GenBank accession 
no. GI: 81722) obtained from Ambion, Inc. (TX): 
small interfering RNA against RAGE (sense, 5'- 
GCUAGAAUGGAAACUGAACTT-3'; antisense, 5'- 
GUUCAGUUUCCAUUCUAGCTT-3'). Smooth muscle 
cells were transfected with si-RAGE duplexes by 
using siPORT NeoFX (Ambion, TX). Briefly, RNA 
duplex (10 nM of final concentration) was incu-
bated in serum-free DMEM containing 15 μl of 
siPORT NeoFX for 10 min. The complex was 
added to the empty 60 mm culture plate and then 
overlay smooth muscle cell suspension (1× 105 
cells per plate) onto the culture plate wells con-
taining transfection complexes and the transfected 
cells were incubated in normal cell culture con-
ditions until ready for assay. 
Measurement of intracellular ROS generation
RAoSMCs were labeled with 2', 7'-dichlorodihydro-
fluorescein diacetate (H2DCFDA; Molecular Probe, 
Eugene, OR) (Lee et al., 2004). The probe 
H2DCFDA (5M) enters the cell and the acetate 
group on H2DCFDA is cleaved by cellular 
esterases, trapping the nonfluorescent 2', 7'-dichlo-
rofluorescin (DCF) inside. Subsequent oxidation by 
reactive oxygen species yields the fluorescent 
product DCF. The dye, when exposed to an exci-
tation wavelength of 480 nm, emits light at 535 nm 
only when it has been oxidized. Labeled RAoSMCs 
were examined using a luminescence spectro-
photometer for oxidized dye. The quiescent cells 
were treated with AGE for 3 h before labeling with 
H2DCFDA. 
Data analysis
At least three independent experiments were con-
ducted for the analysis. The non-parametric Mann- 
Whitney U test was used to analyze mean values, 
and P value of＜0.05 was considered statistically 
significant.
Results
Expression of RAGE in human carotid atheroma
Carotid atheroma specimens showed a thickened 
intima associated to an area of necrotic core and 
lipid-laden atheroma in all cases. RAGE was 
stained as dark brown within atheromatous plaques. 
RAGE stained cells were distributed mainly in the 
base of atherosclerotic plaque, in the medio-intimal 
junction area and its immunoreactivity was co- 
localized with macrophage, mononuclear cells, and 
smooth muscle cells (Figure 1). 
Proliferative effect of AGEs in cultured RAoSMC
Compared with controls AGEs stimulation group 
showed increased smooth muscle proliferation. 
RAoSMC proliferation was increased until AGEs 
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Figure 5. Inhibition of RAGE expression by 
siRNA for RAGE. RAoSMCs were transfected 
with siRNA to a final concentration of 10 nM or 
vehicle and stimulated by AGE for 3 h. Each 
signal was detected by immunoblot analysis 
using anti-ERK antibody and was quantified by 
densitometrical analysis. Expression of RAGE 
protein was reduced by RNA interference by 
Western blot analysis. The ERKs activation in-
creased by AGEs was decreased by RNA inter-
ference for RAGE, indicating that AGEs acti-
vated ERKs via RAGE.
Figure 4. Effects of AGEs on phosphorylation of ERK in cultured RAoSMC. (A) Effects of different concentration of AGEs stimulation on phosphorylation 
of ERK. Activity of p-ERK was increased in AGEs stimulation group compared with control group. AGEs stimulates phosphorylation of ERK in concen-
tration dependent manner. (B) Effect of increased AGEs stimulation duration on phosphorylation of ERK. ERK phosphorylation was increased after 30 min 
of stimulation and continuously increased with the prolonged exposure of AGEs.
concentration 100 μg/ml suggesting AGEs increase 
cell proliferation by concentration dependent manner 
(Figure 2).
Effects of AGEs on phosphorylation of MAPKs in 
RAoSMC
Western blot analysis of p-ERK, p-JNK, p-P38 were 
performed in cultured RAoSMC with or without 
AGE stimulation. Compared with control group, 
VSMC cultured with 50 μg/ml concentration AGE 
stimulation revealed increased phosphorylation of 
MAPK system. Activity of p-ERK and p-P38 was 
markedly increased in AGE stimulated group 
comparing with p-JNK (Figure 3).  
Effects of AGEs on phosphorylation of ERK in 
cultured RAoSMC
Activity of p-ERK was increased in AGEs stimulation 
group compared with control group. AGEs stimu-
lates phosphorylation of ERK in concentration 
dependent manner (Figure 4A). Phosphorylation of 
ERK was increased with the prolonged exposure 
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Figure 6. Effect of AGEs on the formation of intracellular ROS. Confocal 
microscopy of intracellular DCF revealed increased DCF fluorescence 
with AGE stimulation concentration dependently suggesting AGEs in-
creased intracellular ROS. Asterisk indicate statistically significant differ-
ence (P＜ 0.05).
with the AGEs (Figure 4B). 
Inhibition of RAGE expression by siRNA for RAGE
To further confirm whether the phosphorylation of 
ERKs was specific response for AGEs treatment, 
siRNA for RAGE was treated and activation level 
of ERKs was estimated. Expression of RAGE 
protein showed reduction of 90% by RNA inter-
ference and was detected by Western blot analysis. 
The ERKs activation increased by AGEs was 
decreased by RNA interference for RAGE, indi-
cating that AGEs activated ERKs via RAGE 
(Figure 5).
Effects of AGEs on the formation of intracellular ROS
Confocal microscopy of intracellular DCF revealed 
increased DCF fluorescence with AGE stimulation 
concentration dependently suggesting AGEs increa-
sed intracellular ROS (Figure 6).
Discussion 
One of the challenges in cardiovascular medicine 
is reducing the complications in patients after 
percutaneous coronary intervention (PCI), especially 
for those who with diabetes mellitus, who are 
particularly prone to ISR. Although ISR have much 
decreased with the use of DES recently, but DES 
itself has other unexpected complications such as 
late stent thrombosis. It is well known that 
restenosis and overall consequent adverse cardiac 
events are more frequent in diabetics compared 
with non-diabetics who underwent PCI even with 
the DES. This finding may reflect differences in the 
nature of restenosis in this population compared 
with that in non-diabetic subjects undergoing com-
parable interventions. Although, a few studies have 
identified the clinical and angiographic predictors of 
restenosis in diabetes patients, all the factors 
relating to the probability of restenosis after stent 
deployment in this high-risk patients subgroup are 
not known (West et al., 2004). Our previous study 
demonstrated that the rate of angiographic ISR 
was significantly higher in diabetic patients whose 
serum AGEs level was high compared with low 
AGEs group (Choi et al., 2005). In the current 
study we also demonstrated basal immunoreac-
tivities of RAGE in human atheroma taken from 
diabetic patients. RAGE stained cells were distributed 
mainly in the base of the plaque, in the medio- 
intimal junction area and its immunoreactivity was 
co-localized with smooth muscle cells which 
advocate the relation between AGE/RAGE interaction 
and VSMC proliferation.
In the setting of hyperglycemia in diabetes, 
long-term exposure of free amino groups on 
polypeptides or lipids to higher levels of glucose 
eventuates in the formation of AGEs (Brownlee 
1995). AGEs are increased at sites of atheros-
clerotic lesions, especially in diabetes (King and 
Brownlee, 1996; Chappey et al., 1997). Increased 
expression of AGEs has also been found in settings 
like renal failure and amyloidosis, indicating the 
biology of AGEs extends beyond diabetes. The 
cellular effects of AGEs are largely mediated by 
their specific engagement of cell surface receptor 
RAGE. Studies have demonstrated RAGE expression 
at a very low level in a range of cells, including 
endothelial and smooth muscle cells and mono-
nuclear cells, RAGE expression increases and 
receptor upregulation is sustained when particular 
pathological processes intervene (Brett et al., 
1993; Ritthaler et al., 1995).
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Several recent experimental studies showed that 
AGEs can actively participate in neointimal formation 
after arterial injuries. Zhou et al. demonstrated that 
there was significantly increased accumulation of 
AGEs and increased immunoreactivities of RAGE 
and S100/calgranulins in carotid artery of diabetic 
rats in response to balloon injury compared with 
that of nondiabetic rats. Blockade of the RAGE/ 
ligand interaction significantly decreased the S100- 
stimulated VSMC proliferation in vitro and suppre-
ssed neointimal formation, and increased luminal 
area in both Zucker diabetic and nondiabetic rats. 
These findings indicate that RAGE/ligand interac-
tion plays a key role in neointimal formation after 
PCI, especially in diabetics and suggest the plau-
sibility of RAGE blockade as a therapeutic target in 
vascular injury, both in euglycemia and diabetes. 
An increasing body of literature has begun to 
elucidate the pathobiological mechanisms underlying 
the RAGE/ligand interaction. AGEs has been 
shown to induce significant dose-dependent SMC 
migration (Higashi et al., 1997), and RAGE/ligand 
interaction upregulates the production of various 
cytokines and growth factors such as TNF-α (Miyata 
et al., 1996) and PDGF (Yamamoto et al., 1996). 
SMC migration by AGEs was significantly inhibited 
by an antibody TGF-β, and TGF-β secreted into the 
culture medium from AGE-stimulated VSMC was 
7-fold higher than that of control, suggesting a 
potential role for RAGE/ligand interaction in TGF-β 
release after vascular injury (Higashi et al., 1997). 
In addition, binding of RAGE to its ligand leads to 
activation of key cell signaling pathways, such as 
p44/p42 (ERK1/2), p21ras, MAP kinases, NF-κB, 
cdc42/rac, and JAK/Stat, thereby reprogramming 
cellular properties (Lander et al., 1997; Huttunen et 
al., 1999). Adhesion and migration of aortic 
VSMCs are suppressed by inhibitors of PI3K, ERK, 
protein tyrosine kinase, and Src kinase (Lee et al., 
2006). Angiotensin II induced VSMC proliferation is 
also associated with increased phosphorylation of 
ERK 1/2, JNK 1/2 and p-38 (Won et al., 2006)
Balloon injury activates the MAPK pathway in 
diabetics, and hyperinsulinemia activation of the 
MAPK pathway has been shown to be of importance 
in the exaggerated neointimal hyperplasia after 
balloon injury in diabetic animals (Indolfi et al., 
2001). Blockade of RAGE/ligand interaction de-
creases MAPK activity in cultured SMCs in a 
concentration-dependent manner (Lander et al., 
1997). In our study, we demonstrated VSMC proli-
feration by AGEs stimulation and these increased 
VSMC proliferation was due to the increased 
phosphorylation of ERK and p-38, which are very 
important in MAPK signaling pathway. AGEs sti-
mulated VSMC proliferation and MAPKs pho-
sphorylation were increased by time and concen-
tration dependent manner. In our data, AGEs 
induced ERK phosphorylation was continuously 
increased by the stimulation duration. However, 
Lander et al. previously demonstrated that AGE 
induced MAPK activation was peaked at 10 min 
after stimulation and reduced thereafter. As 
activation of MAPK is typically an early event in 
cellular activation, continuous increment of ERK 
phosphorylation might be caused by secondary 
activation of other cytokines. This observation 
should be confirmed by future experiment using 
ERK downstream molecule. ERK-p-38 signaling is 
also activated by AGE/RAGE interaction and 
RAGE blockade reduces its activation (Li et al., 
2004). Our data also demonstrated that AGEs 
stimulation increased p-38 phosphorylation. 
Our previous serologic study of diabetic PCI 
patients revealed high serum levels of AGEs which 
was independent risk factor for ISR were signifi-
cantly correlated with HbA1C and time duration of 
diabetes (Choi et al., 2005). Considering the in 
vitro and serologic study results, it can be explained 
that restenosis and increased atherosclerosis of 
the diabetic patients are related to the high serum 
levels of AGEs, which represented time dependent 
exposure of poor glycemic control. 
Recent study revealed that AGEs and RAGE 
interaction triggers the intracellular reactive oxygen 
species (ROS). Activated NADPH oxidase is a 
central target of RAGE and that ROS generated by 
this mechanism may significantly impact on cellular 
properties (Wautier et al., 2001). Li et al. (2007) 
recently reported that high extracellular glucose 
significantly increases ROS generation and AGEs 
formation in human cardiac myocyte and MAPK 
activation is one of possible mechanisms of 
triggering ROS generation. Our study also revealed 
concentration dependent increment of intracellular 
ROS by AGEs stimulation. Future work is warranted 
to examine the relationship between AGEs and 
ROS generation using such as RAGE RNA inter-
ference.
In conclusion, our data suggest a central role for 
AGEs as a key factor promoting VSMC proliferation 
and neointimal hyperplasia after stent deployment 
in diabetic patients. These observations will give a 
way to the potentially novel target for limiting the 
development and progression of neointimal hyper-
plasia by AGEs.
Acknowledgment
This work is supported by research grant of Korean 
Society of Circulation and BK21 Project for Medical 
Science, Yonsei University and Korean Instute of Medicine.
AGEs induce proliferation of VSMC 405
References
Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehen-
berger P, Illmer T, Luther T, Berentshtein E, Tritschler H, 
Müller M, Wahl P, Ziegler R, Nawroth PP. Advanced glycation 
endproduct-induced activation of NF-κB is suppressed by 
alpha-lipoic acid in cultured endothelial cells. Diabetes 
1997;46:1481-90
Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky 
D, Nowygrod R, Neeper M, Przysiecki C, Shaw A. Survey of 
the distribution of a newly characterized receptor for 
advanced glycation end products in tissues. Am J Pathol 
1993;143:1699-712
Brownlee M, Cerami A, Vlassara H. AGEs in tissue and the 
biochemical basis of diabetic complications. N Engl J Med 
1988;318:1315-21
Brownlee M. Advanced glycosylation in diabetes and aging. 
Ann Rev Med 1995;46:223-34
Chappey O, Dosquet C, Wautier MP, Wautier JL. Advanced 
glycation end products, oxidant stress and vascular lesions. 
Eur J Clin Invest 1997;27:97-108
Choi EY, Kwon HM, Ahn C, Lee GT, Joung B, Hong BK, Yoon 
YW, Kim D, Byun KH, Kang TS, Yoon SJ, Kwon SW, Lee SJ, 
Park JK, Kim HS. Serum levels of advanced glycation 
endproducts are associated with in-stent restenosis in 
diabetic patients. Yonsei Med J 2005;46:78-85
Diabetes Control and Complications Trial (DCCT) Research 
Group. The effect of intensive treatment of diabetes on the 
development and progression of long-term complications in 
insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 
977-86
Higashi T, Sano H, Saishoji T, Ikeda K, Jinnouchi Y, Kanzaki 
T, Morisaki N, Rauvala H, Shichiri M, Horiuchi S. The receptor 
for advanced glycation end products mediates the chemo-
taxis of rabbit smooth muscle cells. Diabetes 1997;46: 
463-72
Huttunen HL, Fages C, Rauvala H. Receptor for advanced 
glycation endproducts (RAGE)-mediated neurite outgrowth 
and activation of NF-κB require the cytoplasmic domain of 
the receptor of but different downstream signaling pathways. 
J Biol Chem 1999;274:19919-24
Hwang KC, Lee KH, Jang Y. Inhibition of MEK1,2/ERK 
mitogenic pathway by estrogen with antiproliferative 
properties in rat aortic smooth muscle cells. J Steroid 
Biochem Mol Biol 2002;80:85-90 
Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, 
Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, 
Stabile E, Perrino C, Chieffo A, Pardo F, Chiariello M. Effects 
of balloon injury on neointimal hyperplasia in streptozocin- 
induced diabetes and in hyperinsulinemic nondiabetic 
pancreatic islet transplanted rats. Circulation 2001;103: 
2980-6
Kannel WB, McGee DL. Diabetes and cardiovascular 
disease: The Framingham Study. J Am Med Assoc 1979; 
241:2035-38
King G, Brownlee M. The cellular and molecular mechanisms 
of diabetic complications. Endocrinol Metab Clin North Am 
1996;25:255-70
Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. 
In-stent restenosis: contributions of inflammatory responses 
and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 
1998;31:224-30
Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt 
AM. Activation of the receptor for advanced glycation 
endproducts triggers a p21(ras)-dependent mitogen-activated 
protein kinase pathway regulated by oxidant stress. J Biol 
Chem 1997;272:17810-4
Lee BH, Bae JS, Park RW, Kim JE, Park JY, Kim IS. Βig-h3 
triggers signaling pathways mediating adhesion and 
migration of vascular smooth muscle cells through αvβ5 
integrin. Exp Mol Med 2006;38:153-61
Lee KH, Lim S, Kang SM, Kim DH, Cho HK, Chung JH, Kwon 
HM, Chung H, Lee H, Jang Y, Hwang KC. Antiproliferative 
mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat 
aortic smooth muscle cells. Eur J Pharmacol 2004;484: 
119-25
Li JH, Huang XR, Zhu H, Oldfield M, Cooper M, Truong LD, 
Johnson RJ, Lan HY. Advanced glycation end products 
activate Smad signaling via TGF-β-dependent and- 
independent mechanisms: implications for diabetic renal 
and vascular disease. FASEB J 2004;18:176-8
Li SY, Sigmon VK, Babcock SA, Ren J. Advanced glycation 
endproduct induced ROS accumulation, apoptosis, MAP 
kinase activation and nuclear O-GlcNAcylation in human 
cardiac myocytes. Life Sci 2007;80:1051-6
Miyata T, Hori O, Zhang J, Yan SD, Ferran L, Iida Y, Schmidt 
AM. The receptor for advanced glycation end products 
(RAGE) is a central mediator of the interaction of AGR-β2 
microglobulin with human mononuclear phagocytes via an 
oxidant-sensitive pathway: implications for the patho-
genesis of dialysis-related amyloidosis. J Clin Invest 1996; 
98:1088-94
Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, 
Allenberg J, Otto G, Roth H, Bierhaus A, Ziegler R, Schmidt 
AM, Waldherr R, Wahl P, Stern DM, Nawroth PP. Expression 
of RAGE in peripheral occlusive vascular disease. Am J 
Pathol 1995;146:688-94
Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, 
Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, 
Nawroth PP, Stern DM, Schmidt AM, Naka Y. Central role of 
RAGE-dependent neointimal expansion in arterial reste-
nosis. J Clin Invest 2003;111:959-72
Stephenson K, Tunstead J, Tsai A, Gordon R, Henderson S, 
Dansky HM. Neointimal formation after endovascular arterial 
injury is markedly attenuated in db/db mice Arterioscler 
Thromb Vasc Biol 2003;23:2027-33
Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, 
Pyorala K. Five-year incidence of atherosclerotic vascular 
disease in relation to general risk factors, insulin level, and 
abnormalities in lipoprotein composition in non-insulin- 
406 Exp. Mol. Med. Vol. 40(4), 398-406, 2008
dependent diabetic and non-diabetic subjects. Circulation 
1990;82:27-36
Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, 
Meurice T, McFadden EP, Lablanche JM, Bertrand ME. 
Restenosis rates in diabetic patients: a comparison of 
coronary stenting and balloon angioplasty in native coronary 
arteries. Circulation 1997;96:1454-60
Vlassara H, Bucala R, Striker LJ. Pathogenic effects of 
advanced glycation: Biochemical, biological, and clinical 
implications for diabetes and aging. Lab Invest 1994;70: 
138-51
Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, 
Wautier JL. Activation of NADPH oxidase by AGE links 
oxidant stress to altered gene expression via RAGE. Am J 
Physiol Endocrinol Metab 2001;280:685-94
West NE, Ruygrok PN, Disco CM, Webster MW, Lindeboom 
WK, O'Neill WW, Mercado NF, Serruys PW. Clinical and 
angiographic predictors of restenosis after stent deployment 
in diabetic patients. Circulation 2004;109:867-73
Won SM, Park YH, Kim HJ, Park KM, Lee WJ. Catechins 
inhibits angiotensin II-induced vascular smooth muscle cell 
proliferation via mitogen-associated protein kinase pathway. 
Exp Mol Med 2006;38:525-34
Yamamoto Y, Yamagishi S, Hsu CC, Yamamoto H. Advanced 
glycation end products-receptor interactions stimulate the 
growth of human pancreatic cancer cells through the 
induction of platelet-derived growth factor-B. Biochem 
Biophys Res Commun 1996;222:700-5
Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, 
Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol 
EJ. Receptor for AGE (RAGE) mediates neointimal forma-
tion in response to arterial injury. Circulation 2003;107: 
2238-43
